NMRA
NASDAQStockNeumora Therapeutics, Inc. Common Stock
$3.04-0.10 (-3.18%)
52-Week Range
$0.62
$3.59
Key Stats
Market Cap
508.0M
P/E Ratio
—
Dividend Yield
—
Beta
2.53
Volume
460.9K
Avg Volume
862.0K
Performance
1M
-3.38%
3M
+60.20%
6M
+106.58%
YTD
+89.16%
1Y
+145.31%
3Y
-80.68%
5Y
-80.68%
Price Chart
ETF Exposure
NMRA is held by 18 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| SBIO.L | Invesco NASDAQ Biotech UCITS ETF | 0.04% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.04% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 0.03% |
| PRFZ | Invesco RAFI US 1500 Small-Mid ETF | 0.03% |
| IBB | iShares Biotechnology ETF | 0.02% |
| SCHA | Schwab U.S. Small-Cap ETF | 0.01% |
| AVSC | Avantis U.S. Small Cap Equity ETF | 0.00% |
| VHT | Vanguard Health Care ETF | 0.00% |
| VXF | Vanguard Extended Market ETF | 0.00% |
| DFAS | Dimensional - US Small Cap ETF | 0.00% |
| AVTM | Avantis Total Equity Markets ETF 1 | 0.00% |
| SCHB | Schwab U.S. Broad Market ETF | 0.00% |
| VCNS.TO | Vanguard Conservative ETF Portfolio | 0.00% |
| VEQT.TO | Vanguard All-Equity ETF Portfolio | 0.00% |
| VRIF.TO | Vanguard Retirement Income ETF Portfolio | 0.00% |
| VTI | Vanguard Total Stock Market ETF | 0.00% |
| VUN.TO | Vanguard U.S. Total Market Index ETF | 0.00% |
| VUS.TO | Vanguard U.S. Total Market Index ETF (CAD-hedged) | 0.00% |
About NMRA ETF Exposure
Neumora Therapeutics, Inc. Common Stock (NMRA) is held by 18 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 508.0M, NMRA is a widely held institutional stock. The stock currently trades at $3.04. Investors can gain exposure to NMRA through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold NMRA, sorted by portfolio weight.